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ABSTRACT
Our purpose is to provide a summary overview of blindness and visual impairment on the context of recent Brazilian
ocular epidemiologic studies. Synthesis of data from two cross-sectional population-based studies – the São Paulo
Eye Study and the Refractive Error in School Children Study is presented. 3678 older adults and 2441 school children
were examined between July 2004 and December 2005. Prevalence of blindness in older adults using presenting visual
acuity was 1.51% decreasing to 1.07% with refractive correction. The most common causes of blindness in older adults
were retinal disorders, followed by cataract and glaucoma. In school children, the prevalence of uncorrected visual
impairment was 4.82% decreasing to 0.41% with refractive correction. The most common cause of visual impairment
in school children was uncorrected refractive error. Visual impairment and blindness in Brazil is an important public
health problem. It is a significant problem in older Brazilians, reinforcing the need to implement prevention of
blindness programs for elderly people with emphasis on those without schooling. In school-children cost-effective
strategies are needed to address a readily treatable cause of vision impairment – prescription and provision of glasses.
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INTRODUCTION
Visual impairment and blindness have a significant im-
pact on the socioeconomic development of individuals
and societies. Their consequences are an important
public health issue with greater impact in the develop-
ing countries, where 80% of the world blindness occurs
(Congdon et al. 2003). Visual impairment, which may
be defined as blindness (best-corrected vision of < 20/
400 in the better vision eye, by the World Health Or-
ganization [WHO]) or low vision (best-corrected vision
< 20/60 in the better vision eye according to WHO), is
one of the most common disabilities: currently, there are
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worldwide an estimated 37 million people with blind-
ness and 124 million people with low vision (Resnikoff
et al. 2004). Most of them have lost their sight to dis-
eases that are treatable or preventable (Pizzarello et
al. 2004).
The number of individuals with blindness might
reach 76 million by 2020. The most significant factor
is the decline in both mortality and fertility rates, con-
tributing to a rapid aging of populations in most coun-
tries (West and Sommer 2001). More than 82% of all
blind persons are 50 years of age or older. Given pro-
jected demographic changes and population growth,
the incidence of chronic, non-communicable diseases
affecting eyesight is expected to increase (Resnikoff
et al. 2004).
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To reduce this estimated doubling of blind cases, a
lot of effort will be required in the future. In response
to this global need, the WHO launched in 1999 the Vi-
sion 2020: The Right to Sight, an initiative in partner-
ship with non-governmental organizations (NGOs) and
eye care organizations (Pararajasegaram 1999). Vision
2020 aims to eliminate avoidable blindness in the world
by 2020 and targets the world’s leading causes of avoid-
able visual impairment (Pizzarello et al. 2004). Analysis
of global epidemiological data on the pattern of blind-
ness indicates that up to 75% of the cases are avoid-
able. Avoidable blindness is defined as blindness which
could be either treated or prevented by known, cost-
effective means. Among the main causes of avoidable
blindness are cataract, refractive errors (myopia, hyper-
opia and astigmatism), glaucoma, diabetic retinopathy
and age-related macular degeneration.
Prevention of avoidable visual impairment leads to
substantial long-term savings in health-care and social
expenditures, in proportion to the number of individ-
uals who no longer need medical or social assistance.
Savings also accrue from the significantly reduced com-
mitment made by family members caring for a visually
impaired person. There is a direct link between the so-
cial and economic deprivation experienced by visually
impaired individuals (specifically those in lower-income
countries) and their ability to seek and obtain medical
care. The resulting downward socioeconomic spiral can
be reversed through widely available, appropriate, cost-
effective preventive and curative interventions (WHO
2006).
Since the prevention of blindness and visual im-
pairment is a high priority topic in public health, there
is a continuing need for population-based studies to pro-
vide an up-to-date characterization of the magnitude and
nature of the blindness problem. Societal changes and
medical advances in the last decades have resulted in
corresponding changes in the burden of blindness and
visual impairment. Progressive urbanization, longer life
expectancy, and behavioral changes in many parts of the
world have contributed to an increase of newly emergent
blindness causes, such as diabetic retinopathy and age-
related macular degeneration, and a decrease of classical
causes, such as oncocerchiasis, trachoma and xeroph-
thalmia. Identification of the prevalence and causes of
visual impairment and blindness are crucial for the es-
tablishment of local programs and supra-national, con-
tinental and world prevention strategies. This informa-
tion is of critical importance for both scientists and in-
ternational agencies working in the field.
Brazil is an example of a country which experi-
enced important social changes in the last decades of
the 20th century, with massive urbanization and the im-
plementation of modern medical care radically shifting
the public health landscape. Several medical areas had
beneficial impact, among them successful programs for
HIV infection prevention and a new initiative to improve
access to modern cataract surgery.
Due to initiatives to improve access to modern cat-
aract surgery implemented by health authorities in the
late 90’s, Brazil has built a reputation of positive trend
in eye care delivery services into the international pre-
vention of blindness community. This fact, in addition
to the scarcity of reliable epidemiological data, had mo-
tivated WHO to choose Brazil as a target country to
perform an extensive population-based eye survey. The
objective of this ambitious project was to investigate
prevalence and causes of visual impairment and blind-
ness in two specific populations: older adults and school-
age children.
This article aims to review current knowledge for
the main causes of visual loss, with a focus on recent
population-based studies performed in a low-middle
income region of São Paulo city in older adults and
school-age children.
DEFINITION OF BLINDNESS AND VISUAL IMPAIRMENT
Blindness is defined either in terms of best-corrected dis-
tance visual acuity (the most appropriate refractive cor-
rection) or presenting distance visual acuity (the indi-
vidual’s current refractive correction) in the better eye.
Also of importance in the definition of blindness is the
level of visual acuity that is applied. Visual acuity levels
of < 20/400 or < 20/200 in the better eye have been
commonly used to define blindness. Visual impairment
is defined as visual acuity of 20/60 or less in the better
acuity eye (Dandona and Dandona 2006).
Many population-based surveys from less devel-
oped countries have reported blindness rates using visual
acuity level less than 20/400 (Pascolini et al. 2004). The
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more developed countries have often used visual acu-
ity less than 20/200 to define blindness (Congdon et al.
2004, Laitinen et al. 2005, Taylor et al. 2005). In mod-
ern times, the importance of visual tasks, such as driving
and reading, means that vision loss should be classified
in several visual categories for a thorough description
of visual impairment spectrum. In a recent prevalence
survey in elderly urban population in Brazil, following
previous epidemiological surveys in developing coun-
tries, several visual impairment categories were studied
(Araújo-Filho et al. 2008).
PREVALENCE AND CAUSES OF VISUAL IMPAIRMENT
AND BLINDNESS
The prevalence of blindness is defined as the number of
affected individuals per hundred population in a given
period of time. It can vary considerably among coun-
tries depending on socio-economic factors and available
health and eye care services. A prevalence of 0.25 in
the general population is expected in communities with
good economy and health services, rising to 1.0 or more
in communities with very poor economy and health ser-
vices. The difference in prevalence is mainly because
blindness from cataract, refractive errors, and corneal
scarring (trachoma, corneal infections, and vitamin A de-
ficiency) has been eliminated in communities with good
economy and eye services. The problem of cataract
blindness in the industrialized world has been largely
solved through the availability of affordable, high-qual-
ity surgery with intraocular lens (IOL) implantation, re-
sulting in cataract-care delivery that equals or is greater
than the incidence of visually disabling cataract (Apple
et al. 2000).
The South American section of Vision 2020 ini-
tiative has determined cataract, childhood blindness, re-
fractive error and diabetic retinopathy as target diseases
for the region. The objective is to improve cataract sur-
gical rates, detection and treatment of retinopathy of
prematurity and low vision and refractive services
(Pizzarello et al. 2004).
Cataract
Cataract – an opacity in the normally clear, crystalline
lens of the eye – is a major cause of blindness world-
wide. Recent estimates suggest that 18 million people
(48% of all cases) are blind from cataract (Resnikoff et
al. 2004). The prevalence of cataract also increases with
age in developing countries (Brian and Taylor 2001).
Many risk factors are associated with the onset and the
progression of cataract: metabolic diseases (diabetes),
chronic UV-B light exposure, medications (steroids),
smoking and genetics (West 2007). Since cataract can be
removed by with an easy, safe and cost-effective surgical
procedure, this condition is a potentially curable form
of blindness. The challenge to deal with this curable
cause of blindness is to provide available high-volume,
low-cost, safe and high-quality surgery with affordable
intra-ocular lenses in appropriate eye health care centers.
A compilation of previous studies of adults of 50
years of age and older in Latin America focused on
evaluating blindness due to cataract using a simplified
ophthalmic exam described in the Rapid Assessment of
Cataract Surgical Services (RACSS) protocol has identi-
fied cataract as a main cause of blindness, ranging from
41% in urban Brazil to 87% in rural Peru (Limburg et
al. 2008).
Data from population-based studies on surgical fol-
low-up are essential for the assessment of the procedure
quality and its final visual acuity outcomes. Evaluation
of postoperative results should consider good present-
ing visual acuity, low rate of complications and good
quality of life related to vision, so that activities such as
driving, reading, sewing, interpersonal interactions, and
computer skills can be restored.
Prevention of cataract blindness can be pursued by
avoidance of known risk factors, as well as education
programs to encourage those at risk of blindness to ob-
tain comprehensive ophthalmologic examination on a
regular basis. Other cultural aspects have also to be ad-
dressed. Acceptance of impaired sight as an inevitable
consequence of old age, fear of the operation, contact
with individuals who have had bad experiences, lack of
encouragement from the family, lack of knowledge con-
cerning where surgery is provided, distance from the ser-
vice, lack of a person to accompany the patient to the hos-
pital, poor state of hospitals, long waiting lists, and cost
are the main barriers to the uptake of cataract services
(Hubley and Gilbert 2006).
An Acad Bras Cienc (2009) 81 (3)
“main” — 2009/7/27 — 15:30 — page 542 — #4
542 SOLANGE R. SALOMÃO, MÁRCIA R.K.H. MITSUHIRO and RUBENS BELFORT Jr.
Refractive error
Refractive errors (myopia, hyperopia and astigmatism)
affect a large proportion of the population worldwide,
irrespective of age, sex and ethnic group. They can be
easily diagnosed, measured and corrected with specta-
cles or other refractive corrections to attain normal vi-
sion. If, however, they are not corrected or the correction
is inadequate, refractive errors become a major cause
of low vision and even blindness. Visual impairment
from uncorrected refractive errors can have immediate
and long-term consequences in children and adults, such
as lost educational and employment opportunities, lost
economic gain for individuals, families and societies,
and impaired quality of life. Various factors are respon-
sible for refractive errors remaining uncorrected: lack
of awareness and recognition of the problem at personal
and family level, as well as at community and public
health level; non-availability of and/or inability to afford
refractive services for testing; insufficient provision of
affordable corrective lenses; and cultural disincentives
to compliance (Resnikoff et al. 2008).
Refractive error as a cause of blindness has not
received much attention because many definitions of
blindness have been based on best-corrected distance vi-
sual acuity, including the definition used in the Inter-
national Statistical Classification of Diseases and Re-
lated Health Problems – ICD-10 (Dandona and Dan-
dona 2006). A major limitation of ICD-10 categories
is that they do not allow refractive errors to be assessed
as cause of visual impairment. The WHO recently sug-
gested that “presenting visual acuity” (i.e. visual acuity
obtained with currently available refractive correction,
if any), as well as uncorrected visual acuity, be used in
all population-based surveys. Thus, presenting vision as
opposed to best-corrected vision provides the prevalence
of visual impairment that could be improved simply by
appropriate corrective refraction (Resnikoff et al. 2008,
Gilbert et al. 2008).
A recent compilation of surveys performed in sev-
eral regions of the world showed an estimated 153 mil-
lion people to be visually impaired from uncorrected
refractive errors, of whom eight million are blind (Res-
nikoff et al. 2008). Actions to prevent blindness and
visual impairment due to refractive errors include im-
plementation of large scale vision screening programs,
sufficient personnel to perform quality refraction and
provision of affordable quality spectacles (Dandona and
Dandona 2001).
Age-related Macular Degeneration (AMD)
Age-related macular degeneration (AMD) is a disorder
of the macular area of the retina, most often clinically
apparent after 50 years of age, characterized by discrete
whitish-yellow spots identified as “drusen” which are
external to the neuroretina or the retinal pigmented ep-
ithelium (RPE) and may be soft or hard. The disciform
variant of this disorder was first labeled senile macular
degeneration. In the most severe forms of AMD, either
the RPE may atrophy completely (geographic atrophy
or “dry AMD”), or growth of new vessels and leakage
can occur (exsudative or “wet AMD”), with possible de-
tachment of the RPE and retina as well (West 2000).
There is currently no effective treatment that will pre-
vent AMD or restore vision once it has been lost. Thus,
research into the pathogenesis and treatment of this dis-
ease should have a high priority.
AMD causes difficulty with tasks requiring central
vision, such as reading, writing, driving and recognizing
faces, and is a leading cause of legal blindness in the
older population in industrialized countries (Klein et al.
2002, Taylor et al. 2005). This very high rate will lead
to an increasing importance of AMD as the population
ages and the number of elderly people increases (Van-
Newkirk et al. 2000).
Risk factors for AMD are increasing age, smoking,
family history, Caucasian ethinicity among others (Wang
et al. 1998). On the other hand, persons with higher ed-
ucation were at lower risk for AMD (Age-Related Eye
Diseases Study Research Group 2000). Pooled data to
assess the prevalence and potential risk factors for late
AMD in three racially similar populations from North
America, Europe, and Australia provide strong and con-
sistent evidence that tobacco smoking is the principal
known preventable exposure associated with any form
of AMD. The findings support further health advocacy
approaches to reduce the tobacco smoking rate, and also
support research to identify possible candidate genes that
may predispose to AMD (Smith et al. 2001).
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Many modalities have been tested for the treatment
of neovascular AMD. Antioxidant supplements were
tested for prevention and to slow the progression of
the disease with some benefit for slowing vision loss
and no preventive effects (Evans 2008). Other types of
treatment have been used for neovascular (exsudative)
AMD: photodynamic therapy with verteporfin, intravit-
real triamcinolone, antivascular endothelial growth fac-
tor (VEGF) agents, such as pegaptanib and, to a greater
extent, ranibizumab and bevacizumab. Recent reports
on the subject suggest that most of these treatments
improve visual acuity of AMD patients, but these are
still short-term results and more research about these
new therapies need to be done (Schmidt-Erfurth and
Pruente 2007).
Diabetic Retinopathy (DR)
Diabetes mellitus is an important public health problem
affecting nearly 200 million people worldwide. Diabetic
retinopathy (DR), a specific microvascular complication
of diabetes, is a major cause of blindness. The prevalence
of DR increases with duration of diabetes, and nearly
all persons with type 1 diabetes and more than 60% of
those with type 2 have some retinopathy after 20 years
(Klein et al. 1998).
The disease can be classified into 2 stages: non-
proliferative and proliferative. In nonproliferative DR,
the earliest visible signs are microaneurysms and reti-
nal hemorrhages. Progressive capillary nonperfusion is
accompanied by the development of cotton-wool spots,
venous beading, and intraretinal microvascular abnor-
malities. Proliferative DR is characterized by the growth
of new blood vessels on the surface of the retina or the op-
tic disc. These abnormal vessels may bleed, resulting in
vitreous hemorrhage, subsequent fibrosis, and tractional
retinal detachment. Diabetic macular edema (DME),
which can occur at any stage of DR, is characterized
by increased vascular permeability and the deposition of
hard exudates at the central retina. Primary interventions,
such as intensive glycemic and blood pressure control,
can reduce the incidence of DR, while secondary inter-
ventions, such as laser photocoagulation, may prevent
further progression of DR and vision loss (Mohamed et
al. 2007).
Identified risk factors for DR are: duration of dia-
betes, hyperglycemia/glycated hemoglobin value, hyper-
tension, hyperlipidemia, pregnancy, nephropathy/renal
disease, obesity, smoking, moderate alcohol consump-
tion and physical inactivity (Klein et al. 1998, van Leiden
et al. 2003, Mohamed et al. 2007).
It is estimated that, in 2002, DR accounted for
about 5% of world blindness, representing almost 5 mil-
lion blind. As the incidence of diabetes gradually in-
creases, there is the possibility that more individuals
will suffer from eye complications which, if not prop-
erly managed, may lead to permanent eye damage. The
control of glycemia decreases the risk of the incidence
and the progression of the retinopathy. If sight threaten-
ing retinopathy is present, timely laser photocoagulation
of the retina decreases the risk of a subsequent severe
visual lesion (WHO 2008).
Glaucoma
In the public health context, glaucoma is an irreversible
optic neuropathy associated with characteristic cupping
of the optic nerve head with corresponding nerve fiber
loss and peripheral and ultimately central visual field
defects (Wolfs et al. 2000, Foster et al. 2002, Congdon
et al. 2003). Glaucoma can be classified into angle clo-
sure and open angle types. Open angle glaucoma (OAG)
is defined as a condition of an intraocular pressure, ar-
bitrarily set at > 21 mmHg, that causes glaucomatous
damage of the optic disc and field loss (West 2000). An
estimated 6.7 million people are blind from glaucoma
worldwide, with almost 70 million affected by the dis-
ease (Congdon et al. 2003).
Although standardization of diagnostic methods,
including intraocular pressure, cup disc ratio, visual field
testing, and inclusion of gonioscopy is required, the pri-
mary risk factor for OAG is elevated intraocular pressure
(West 2000). Recent clinical trials indicate that lowering
the intraocular pressure can prevent the development of
glaucoma in individuals with elevated intraocular pres-
sure, and can decrease the likelihood of progression in
those with early disease (Congdon et al. 2003). The
prevalence of glaucoma clearly rises with age (Wensor
et al. 1998, Wolfs et al. 2000). Risk factors among sib-
lings are age, IOP, myopia, and low blood pressure – IOP
differences (Leske et al. 2001). Also, female gender and
family history of glaucoma increases the risk of OAG.
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Ethnic differences in the prevalence of the various
types of glaucoma are marked (Leske 2007). Data from
LALES show that Latinos with a predominantly Mex-
ican ancestry in Los Angeles have rates of open-angle
glaucoma (OAG) comparable to those of US blacks, and
significantly higher than those seen in non-Hispanic
whites. According to this study, the high rate of undi-
agnosed OAG in Latinos suggests that the role of early
screening, diagnosis, and management should be further
examined (Varma et al. 2004).
Glaucoma accounts for 10–20% of all blindness
in many countries. In industrialized nations for people
over 40 years of age, its prevalence is 1.5–2% and, in
African populations, it is at least 2–3 times this figure
(Apple et al. 2000). Glaucoma is an increasing problem,
for which treatment is effective if initiated early in the
disease and if suitable specialist ophthalmic services are
available. About current utilization of eye care services,
blacks account for 6.0% of all cataract visits and 13.6%
of all the glaucoma visits. Substantial racial differences
also exist in annual rates of ambulatory visits for both
cataract and glaucoma among those aged 65 and over
(Javitt 1995).
The management of this condition involves explain-
ing a complex health problem and the need to adhere to
a regime of self administered eye drops, or to accept
surgery. Improvements should address locally identified
barriers, which might include quality of clinical care, as
well as all the other non-clinical aspects of care. There
is a need to improve the quality of information provided
to patients to promote adherence to treatment regimes
and follow up, to increase awareness of possible side ef-
fects and action needed to prevent recurrence (Hubley
and Gilbert 2006).
POPULATION-BASED STUDIES IN BRAZIL
Between 2003 and 2005, two population-based surveys
of prevalence and causes of visual impairment and blind-
ness were conducted in an urban low-middle income area
of São Paulo, Brazil: the São Paulo Eye Study (Salomão
et al. 2008) and the Refractive Error in School-Children
– RESC (Salomão et al. 2008). These two surveys used
similar methods previously used in studies performed in
other developing countries such as Nepal (Pokharel et
al. 1998, 2000, Sapkota et al. 2008), China (Zhao et al.
1998, 2000, Li et al. 1999, Michon et al. 2002, He et
al. 2004, 2007); Chile (Maul et al. 2000); India (Murthy
et al. 2001, 2002, Nirmalan et al. 2002, Dandona et al.
2002); South Africa (Naidoo et al. 2003) and Malaysia
(Goh et al. 2005).
Prevalence and causes of visual impairment
and blindness in older adults in Brazil
The São Paulo Eye Study (SPES) was a population-based
study of urban, low-middle income residents of three
districts of São Paulo city (Ermelino Matarazzo, Vila
Jacuí and São Miguel) aged 50 years or older. Detailed
methods have been published previously (Salomão et al.
2008). Briefly, 3768 participants were recruited from
22 randomly selected clusters. A door-to-door house-
hold census was conducted to identify residents who had
lived in their homes for at least 6 months and were aged
50 years and older. The study was carried out from July
2004 to December 2005. The Committee on Ethics on
Research of UNIFESP approved the implementation of
the survey protocol. Human subject research approval of
the original protocol was cleared by the World Health
Organization Secretariat Committee on Research Involv-
ing Human Subjects.
Within each cluster, enumerated persons were in-
vited to the clinical examination station at the nearby
hospital on a mutually agreed upon date. Written in-
formed consent was obtained at the examination sta-
tion using a scripted consent form. The examination
included presenting visual acuity (which was measured
with participant’s spectacles, if usually worn), ophthal-
mic examination of the eyelid, globe, pupillary
reflex, lens and measurement of intra-ocular pressure
(IOP). Best-corrected visual acuity was measured for
those with visual acuity 20/40 or worse, and for those
previously operated for cataract.
For our analysis, all participants were classified ac-
cording to the vision in their better eye. Visual impair-
ment was defined as presenting visual acuity 20/40 or
worse in the better eye. It was attributable to refractive
error if best-corrected visual acuity was 20/32 or better,
and to another cause if best-corrected vision remained
20/40 or worse. Blindness was defined as presenting
visual acuity worse than 20/200 in the better eye and
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was attributable to refractive error if best-corrected vi-
sual acuity was 20/32 or better. Cases of vision impair-
ment not caused by refractive error were attributed to the
disease considered as a principal cause if more than one
disease occurred in the eye.
Data were available for a total of 3678 participants,
with participation rate of 87%. The prevalence of vi-
sual impairment (<20/63 to≥ 20/200) in the better eye
was 4.74% (95% CI: 3.97% –5.53%), and 2.00% (95%
CI: 1.52% –2.49%) with best correction. The prevalence
of presenting bilateral blindness (<20/200) was 1.51%
(95% CI: 1.20% –1.82%), and 1.07% (95% CI: 0.79% –
1.35%) with best-correction. Extrapolating these figures
to the general population of adults aged 50 years or older
in the country, there were 1,120,000 Brazilians with un-
corrected or uncorrectable visual impairment, including
357,000 Brazilians with uncorrected or uncorrectable
blindness. Blindness was shown to be associated not
only with older age, as expected, but also with the lack
of formal education.
Retinal disorders (including diabetic retinopathy,
macular degeneration, retinal detachment, and other reti-
nal causes) were the main cause of blindness, followed
by cataract and glaucoma. One explanation for the rel-
atively high ranking of retinal disorders as a cause of
blindness is the success of the Brazilian initiative to im-
prove access to cataract surgical services. With a more
than tripling of the annual number of cataract surgeries
over the past 5-year period, cataract blindness is likely
to have been significantly reduced and, therefore, blind-
ness due to other ocular diseases/conditions is becoming
more prominent.
Overall, 32% of visual impairment and 6% of pre-
senting blindness was caused by correctable refractive
error, either myopia or hyperopia. In going beyond the
protocol used in the Nepal, China, and India surveys,
this study explicitly included visual acuity < 20/32 to
≥ 20/63 as a category of reduced vision (labeled near-
normal vision) Including this mild impairment, this cat-
egory was considered important in densely populated
urban areas such as São Paulo, where visual require-
ments for driving and work purposes may be more de-
manding. Our finding of uncorrected refractive error as
the primary cause of mild visual impairment is unmis-
takable.
The prevalence of visual impairment and blindness
based on best-corrected visual acuity puts São Paulo in
a position somewhat similar to that in the United States,
where the prevalence of best-corrected visual acuity of
< 20/40 to > 20/200 in the better seeing eye was re-
ported as 1.98% among those 40 years of age, and the
prevalence of blindness ≤ 20/200 as 0.78% (Congdon
et al. 2004).
Because Brazil covers large territory with many so-
cioeconomic and regional discrepancies, additional sur-
veys including rural areas with poor access to eye care
are needed to provide more widely representative esti-
mates of visual impairment and blindness in Brazil.
Prevalence and causes of visual impairment
in school children in Brazil
Clinical evidence suggests that refractive error (RE), in-
cluding amblyopia and strabismus, are common oph-
thalmic disorders in children. However, despite the rec-
ognized importance of correcting refractive anomalies
in children, there are few reliable studies on the type and
prevalence of the various anomalies encountered. RE,
and particularly myopia, places a substantial burden on
the individual and on society. Myopia can have a poten-
tial negative impact on career choice, ocular health, and
sometimes self-esteem. School-age children constitute a
particularly vulnerable group, in which uncorrected RE
may have a dramatic impact on learning capability and
educational potential. Data on RE prevalence and the
utilization of corrective spectacles among school-age
children are needed for eye health care planning.
In addressing the widespread need for population-
based data on childhood refractive error, the Refractive
Error Study in Children (RESC) protocol to assess the
prevalence of visual impairment and refractive error in
children of different ethnic origins and cultural settings
using consistent definitions and methods was developed
(Negrel et al. 2000).
Previous RESC surveys showed that visual impair-
ment, because of refractive error, was uncommon among
children not attending school (Pokharel et al. 2000, Dan-
dona et al. 2002, Naidoo et al. 2003). On the basis
of these findings, a subsequent RESC survey in rural
Yangxi, China was designed using logistically less cum-
bersome school-based sampling (He et al. 2007). Fur-
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ther, because of resistance among parents in providing
consent for cycloplegia, on a recent survey among private
secondary schools in Kathmandu, Nepal, only children
with visual impairment were evaluated with cycloplegic
refraction (Sapkota et al. 2008). The current emphasis
in RESC surveys is, thus, not on evaluating the preva-
lence of refractive errors, but on visual impairment with
refractive error.
The RESC study in Brazil was a population-based
survey using school-based sampling of low-middle in-
come school age children from nine randomly chosen
public schools in the districts of Ermelino Matarazzo,
Vila Jacuí and São Miguel in São Paulo city. A full meth-
odological description has been provided elsewhere
(Salomão et al. 2008). A random sample of 2825 chil-
dren ages 11–14 years registered in grades 5–8 were
invited for a clinical ophthalmologic examination per-
formed in the school. The study was carried out from
June to November 2005. The Committee on Ethics on
Research of UNIFESP approved the implementation of
the survey protocol. Human subject research approval
of the original protocol was cleared by the World Health
Organization Secretariat Committee on Research Involv-
ing Human Subjects.
School authorities contacted the parents/guardian
of each child to obtain informed consent. The examina-
tion included uncorrected and presenting visual acuity
(which was measured with participant’s spectacles, if
usually worn), ocular motility, external eye and anterior
segment (eyelid, conjunctiva, cornea, iris, and pupil).
Subjective cycloplegic refraction was performed in chil-
dren with unaided (uncorrected) visual acuity of 20/40
or worse in either eye. A principal cause for eyes with un-
corrected visual acuity 20/40 or worse was assigned. Re-
fractive error was assigned routinely if acuity improved
to at least 20/32 with refractive correction. Children with
visual impairment that improved with refraction were
prescribed and provided free spectacles, as well as local
medical advice for minor disorders. Children needing
tertiary medical treatment were referred to the eye clinic
at the local UNIFESP unities of Ermelino Matarazzo
Hospital or São Paulo Hospital.
A total of 2,441 children were examined, represent-
ing an examination response rate of 86.4%. The preva-
lence of uncorrected, presenting, and best-corrected vi-
sual acuity 20/40 or worse in the better eye was 4.82%,
2.67%, and 0.41%, respectively. The prevalence of vi-
sual impairment with myopia and visual impairment
with hyperopia, was 5.46% and 2.05% respectively. Re-
fractive error was a cause in 76.8% of children with vi-
sual impairment in one or both eyes; amblyopia, 11.4%;
retinal disorders, 5.9%; other causes, 2.7%, and unex-
plained causes, 7.7%. For those who could benefit from
adequate glasses, 51.9% were without the necessary
correction.
Considering that a significant number of children
are without appropriate refractive correction, the rela-
tively low prevalence of visual impairment with myopia
or hyperopia should not be taken to suggest that refrac-
tive errors are an insignificant contributor to visual dis-
ability in Brazil. Because visual impairment can have
a detrimental impact on social and educational develop-
ment in a child’s life, exploration of cost-effective strate-
gies to eliminate this easily treatable cause of visual im-
pairment are warranted.
CONCLUSIONS
Epidemiological data from two recent population-based
studies in Brazil have brought important contribution for
health authorities to planning and implement eye care ser-
vices. Retinal disorders in older adults and uncorrected
refractive errors in both older adults and school children
are target diseases. Actions to maintain the access to
modern cataract surgery and provision of good quality
affordable glasses are desirable and should be sustain-
able. Retinal diseases are emerging as principal cause of
unavoidable blindness in older adults from urban Brazil-
ian areas, and strategies to address this important issue
are extremely different from those implemented against
cataract blindness. Early diagnosis and adequate ther-
apy for retinal disorders require specific technology, as
well as long-term and permanent care. Since Brazil is
a country with regional and socio-economic disparities,
studies in rural and less privileged areas in the country
are needed for a thorough picture of the magnitude and
causes of visual impairment and blindness.
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RESUMO
Nosso objetivo é fazer uma revisão de cegueira e deficiência
visual no contexto de recentes estudos epidemiológicos ocula-
res brasileiros. É apresentada a síntese dos dados de dois estu-
dos populacionais transversais – o Estudo Ocular de São Paulo
e o Estudo de Erros Refrativos em Escolares. Entre julho de
2004 e dezembro de 2005 foram examinados 3678 adultos e
2441 escolares. A prevalência de cegueira em adultos mais ve-
lhos considerando a acuidade visual apresentada foi de 1,51%
diminuindo para 1,07% com a correção refrativa. As causas
mais comuns de cegueira em adultos mais velhos foram os dis-
túrbios de retina, seguidos de catarata e glaucoma. Em esco-
lares a prevalência de deficiência visual não corrigida foi de
4,82% diminuindo para 0,41% com a correção refrativa. Em
escolares a causa mais comum de deficiência visual foram er-
ros refrativos não corrigidos. A deficiência visual e a cegueira
são um importante problema de saúde pública no Brasil. É um
problema significante em brasileiros mais velhos reforçando a
necessidade de implementação de programas de prevenção de
cegueira para pessoas idosas com ênfase nos indivíduos sem es-
colaridade. Em escolares são necessárias estratégias de custo-
eficácia para atingir uma causa de deficiência visual facilmente
tratável – a prescrição e a provisão de óculos.
Palavras-chave: cegueira, deficiência visual, prevalência, es-
tudo populacional, epidemiologia ocular.
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